799241-79-5

Basic information

• Product Name: Benzenesulfonamide, N-[(2R,3S)-3-[bis(phenylmethyl)amino]-2-hydroxy-4-phenylbutyl]-4-meth oxy-N-(2-methylpropyl)-
• CAS NO: 799241-79-5
• Molecular Formula: C35H42N2O4S
• Molecular Weight: 586.795
• Mol File: 799241-79-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Benzenesulfonamide, N-[(2R,3S)-3-[bis(phenylmethyl)amino]-2-hydroxy-4-phenylbutyl]-4-meth oxy-N-(2-methylpropyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenesulfonamide, N-[(2R,3S)-3-[bis(phenylmethyl)amino]-2-hydroxy-4-phenylbutyl]-4-meth oxy-N-(2-methylpropyl)-(799241-79-5)
• EPA Substance Registry System: Benzenesulfonamide, N-[(2R,3S)-3-[bis(phenylmethyl)amino]-2-hydroxy-4-phenylbutyl]-4-meth oxy-N-(2-methylpropyl)-(799241-79-5)

Safety Data

• Hazardous Substances Data: 799241-79-5(Hazardous Substances Data)

Upstream product

• 63-91-2 L-phenylalanine 
• 123054-12-6 (2S)-N,N-dibenzylphenylalaninal 
• 118970-37-9 (2S,3S)-3-(dibenzylamino)-2-hydroxy-4-phenylbutanenitrile 
• 111060-52-7 (S)-2-(dibenzylamino)-3-phenylpropan-1-ol 
• 100-39-0 benzyl bromide 
• 98-68-0 4-methoxy-phenyl-sulphonyl chloride 
• 169331-42-4 βS--αR-<<(2-methylpropyl)amino>methyl>-benzenepropanol 

Downstream Products

• 1402829-89-3 C₂₅H₃₉N₂O₇PS 
• 1402829-90-6 C₂₉H₄₇N₂O₇PS 
• 206362-00-7 {(1S,2R)-1-Benzyl-2-hydroxy-3-[isobutyl-(4-methoxy-benzenesulfonyl)-amino]-propyl}-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester 
• 157567-13-0 N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-4-hydroxy-N-isobutylbenzenesulfonamide 
• 159005-71-7 N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-methoxybenzenesulfonamide 
• 799241-81-9 N-(3-dibenzylamino-2-hydroxy-4-phenyl-butyl)-4-hydroxy-N-isobutyl-benzenesulfonamide 

Relevant articles and documents

An Efficient Synthesis of a Hydroxyethylamine (HEA) Isostere and Its α-Aminophosphonate and Phosphoramidate Derivatives as Potential Anti-HIV Agents

HIV protease is a promising drug target for AIDS therapy, and several potent HIV-1 protease inhibitors have been reported to date. Although existing inhibitors exhibit high selectivity, they have also been associated with severe side effects and the possi